12:00 AM
 | 
Aug 07, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Thalidomide analogs regulatory update

ENMD received U.S. Patent Nos. 5,712,291 and 6,071,948 covering the use of thalidomide analogs, including EM-138 and amino-thalidomide derivatives, as...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >